Items tagged with Advocacy
The TB Europe Coalition visit to Belarus (post)
As part of a TB Europe Coalition (TBEC) series of field visit, three members of TBEC visited Belarus in November 2014.
MSF video: Push, pull and pool: accelerating innovation and access for new treatment regimens for TB (post)
Current modes of research and development have failed to deliver new and better TB regimens to patients; as such, MSF and others are proposing a new way to conduct TB regimen research, in the form of the 3P project. The ‘3P Project’ aims to rapidly deliver affordable, effective new regimens for TB through an open collaborative approach to conducting drug development, using novel approaches to financing and coordinating R&D.
Support for extension of transitional period and waivers of least developed countries on TRIPS Agreement (post)
The Communities living with HIV and Tuberculosis and affected by malaria Delegation (Communities Delegation) on the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) expresses its full support for the request submitted by Bangladesh at the WTO TRIPS Council in October 2014, on behalf of the Least Developed Countries (LDCs), for an extension of the transitional period under Article 66.1 of the TRIPS Agreement with respect to pharmaceutical products and for waivers from the obligations of Articles 70.8 and 70.9 of the TRIPS Agreement (IP/C/W/605).
With eye on transition, a boost to investment in community systems in EECA (post)
Seeking to bolster local capacity to advocate for resources, implement and monitor programs ahead of countries' graduation from Global Fund eligibility, the International HIV/AIDS Alliance in Ukraine will lead a new regional technical assistance project across Eastern Europe and Central Asia.The project will be supported by the Global Fund's Community, Rights and Gender (CRG) Special Initiative and will run through 2017.
Public consultation on the European Neighboorhood Policy: TBEC calls for greater emphasis on health (post)
The European Commission has launched a public consultation on its next European Neighboorhood Policy. The TB Europe Coalition answers suggesting greater focus be placed on health at the political level. The consultation is open until 30 June. You can submit your contributions by chosing to answer some or all of the questions. All information can be found here.
MSF and DNDi join call for a biomedical research and development fund and mechanism to meet pressing global health needs (post)
A group of renowned global health experts*, including from Médecins Sans Frontières (MSF) and the Drugs for Neglected Diseases initiative (DNDi), are calling for the creation of a global health research and development (R&D) fund and mechanism to address deadly gaps in innovation for emerging infectious diseases such as Ebola, anti-microbial resistance, and a host of other diseases that have been neglected by the pharmaceutical market. The call comes at a time when these and other public health challenges are high on political agendas in the lead up to World Health Assembly next week and the G7 Summit in June.
amfAR: Issue brief: Trans-Pacific Partnership: Curbing access to medicines now and in the future (May 2015) (post)
The Trans-Pacific Partnership (TPP) is currently being negotiated among 12 Pacific Rim countries: Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the United States, and Vietnam. If passed, it will become the largest U.S. free trade agreement (FTA) in history. It is anticipated that the agreement will expand existing intellectual property (IP) protections on pharmaceutical products, which will ultimately impede access to affordable generic medicines for diseases such as HIV/AIDS, cancer, tuberculosis, and hepatitis C.
MSF responds to TB Alliance announcement of the Nix-TB clinical trial (post)
On 13 May, TB Alliance announced the start of its Nix-TB (New Investigational Drugs for XDR-TB) clinical trial, the first to test a new all-oral regimen for extensively drug-resistant tuberculosis (XDR-TB).
South Africa: Minister of Health and TAC call on MPs to get tested for TB (post)
On World Tuberculosis (TB) Day, on the 24th March, the Treatment Action Campaign (TAC) and partner organisations asked Members of Parliament to get tested for TB during the “We die of TB” march. A mobile screening unit was provided outside Parliament by the Desmond Tutu TB Centre. Whilst our memorandum was received by a representative of parliament, no Members of Parliament came out to get tested for TB.
Two UN agencies come out in support of extension of TRIPS LDC waiver (post)
The United Nations Development Programme and the Joint UN Programme on HIV/AIDS have issued a joint statement supporting a request by least-developed countries to extend a waiver allowing them to abstain from enforcing patents on pharmaceutical products.
Page 6 of 127 · Total posts: 0
←First 5 6 7 Last→